A Brussels court has ordered Poland to pay roughly 1.3 billion euros to Pfizer and BioNTech for COVID vaccine doses the country refused to accept. Fletcher and Octavio dig into the procurement scramble that created this mess and what it reveals about pharmaceutical power in a crisis.
Un tribunal de Bruselas ordenó a Polonia pagar 1.300 millones de euros a Pfizer y BioNTech por dosis de vacunas contra el COVID que el país no quiso recibir. Fletcher y Octavio analizan la historia detrás del mayor desastre de contratos farmacéuticos de la pandemia y lo que significa para la próxima crisis sanitaria global.
6 essential B1-level terms from this episode, with translations and example sentences in Spanish.
| Spanish | English | Example |
|---|---|---|
| apelar | to appeal (a legal ruling) | El gobierno decidió apelar la sentencia del tribunal. |
| dosis | dose | Muchos países compraron demasiadas dosis de la vacuna. |
| contrato | contract | El contrato entre Polonia y Pfizer tenía condiciones muy estrictas. |
| sentencia | court ruling / sentence | La sentencia del tribunal ordenó a Polonia pagar 1.300 millones de euros. |
| transparencia | transparency | El Parlamento Europeo pidió más transparencia en los contratos farmacéuticos. |
| excedente | surplus / excess | Polonia tenía un excedente de vacunas que no podía usar. |
Picture a warehouse.
Millions of vaccine doses, refrigerated, labeled, never opened.
And now a court just told the government that ordered them: you owe us a billion and a half euros anyway.
Sí, Fletcher.
Yes, Fletcher.
Esta semana un tribunal de Bruselas ordenó a Polonia pagar unos 1.300 millones de euros a Pfizer y BioNTech.
This week a Brussels court ordered Poland to pay around 1.3 billion euros to Pfizer and BioNTech.
Polonia pidió millones de dosis de vacunas contra el COVID, pero después no las quiso recibir.
Poland ordered millions of COVID vaccine doses, but then refused to accept them.
And Warsaw is appealing.
Which, honestly, tells you they think they have a case.
So walk me through what actually happened here, because the headline makes Poland sound like it just forgot to pick up its online order.
Es más complicado que eso.
It's more complicated than that.
Durante la pandemia, en 2021, muchos países europeos firmaron contratos con Pfizer para comprar muchísimas dosis.
During the pandemic, in 2021, many European countries signed contracts with Pfizer to buy enormous quantities of doses.
Era el momento del pánico.
It was a moment of panic.
Nadie sabía cuántas vacunas iba a necesitar.
Nobody knew how many vaccines they were going to need.
Right.
And this is something I remember viscerally from 2021.
Governments were terrified of being caught short.
The optics of running out of vaccines in a second wave would have been catastrophic.
So everyone ordered more than they probably needed.
Exactamente.
Exactly.
Pero en Polonia el problema fue diferente.
But in Poland the problem was different.
Mucha gente no quería vacunarse.
A lot of people didn't want to get vaccinated.
Había mucha desconfianza hacia las vacunas, especialmente en las zonas rurales y entre personas mayores de algunas regiones.
There was a lot of distrust toward the vaccines, especially in rural areas and among older people in some regions.
Poland's vaccination rate was one of the lowest in the EU.
I think at its peak they were trailing most of Western Europe by fifteen, twenty points.
So they ended up with this surplus they couldn't use, and at some point the government said, we're not taking any more shipments.
Sí.
Yes.
Y Pfizer dijo: no importa.
And Pfizer said: it doesn't matter.
El contrato existe.
The contract exists.
Vosotros firmasteis, nosotros producimos las dosis, y ahora tenéis que pagar.
You signed it, we produced the doses, and now you have to pay.
El tribunal de Bruselas decidió que Pfizer tenía razón.
The Brussels court decided that Pfizer was right.
Before we get into whether that's fair, let's back up for a second.
Because I think people forget how these EU vaccine contracts actually worked.
This wasn't Poland negotiating directly with Pfizer.
The European Commission did that centrally, on behalf of all member states.
Correcto.
Correct.
La Comisión Europea negoció contratos muy grandes con Pfizer, con Moderna, con AstraZeneca.
The European Commission negotiated very large contracts with Pfizer, with Moderna, with AstraZeneca.
Después, cada país miembro tenía que decidir cuántas dosis quería dentro de ese acuerdo general.
Then, each member state had to decide how many doses it wanted within that general agreement.
Polonia pidió muchas.
Poland requested a lot.
And here's the thing I find genuinely interesting about those negotiations: we've since learned that the contracts Pfizer signed with governments were extraordinarily favorable to Pfizer.
Countries couldn't cancel easily.
They couldn't renegotiate.
Some contracts even gave Pfizer the right to seize state assets in disputes.
Sí.
Yes.
Y eso es lo que muchos países protestaron después.
And that's what many countries protested afterward.
Albania, por ejemplo, tuvo problemas similares.
Albania, for example, had similar problems.
También Bulgaria.
Bulgaria too.
Estos contratos eran muy secretos.
These contracts were very secret.
Los parlamentos no podían verlos completos.
Parliaments couldn't see them in full.
Había cláusulas de confidencialidad muy fuertes.
There were very strong confidentiality clauses.
I want to sit with that for a moment.
Governments spending public money on public health contracts that their own legislators couldn't read in full.
That's not a minor thing.
That's a fundamental accountability problem.
Tienes razón.
You're right.
Pero también hay que entender el contexto.
But you also have to understand the context.
En 2021, la presión era enorme.
In 2021, the pressure was enormous.
Los gobiernos querían las vacunas rápidamente.
Governments wanted the vaccines quickly.
Y Pfizer sabía que tenía un producto muy valioso.
And Pfizer knew it had a very valuable product.
En una negociación así, el poder era claramente de Pfizer.
In a negotiation like that, the power was clearly with Pfizer.
A company with a monopoly on something governments desperately need in a crisis.
It's almost a textbook case of monopsony going wrong in reverse.
The buyer has the desperate need, the seller has the leverage.
Exactamente.
Exactly.
Y ahora, años después de la pandemia, Polonia tiene que pagar por dosis que nunca usó.
And now, years after the pandemic, Poland has to pay for doses it never used.
El gobierno polaco dice que las condiciones del contrato no eran justas.
The Polish government says the contract conditions weren't fair.
Que Pfizer usó la crisis para imponer condiciones inaceptables.
That Pfizer used the crisis to impose unacceptable conditions.
Which is a sympathetic argument, until you remember that Poland signed the contract.
A government choosing to sign something in a crisis is still a choice.
I covered enough negotiations in my career to know that 'we panicked' is rarely a complete legal defense.
Sí, pero hay otro problema.
Yes, but there's another problem.
No fue solo Polonia.
It wasn't just Poland.
Francia, Alemania, Italia, muchos países compraron demasiadas vacunas.
France, Germany, Italy, many countries bought too many vaccines.
La Unión Europea en total compró más de cuatro mil millones de dosis para una población de cuatrocientos millones de personas.
The European Union in total bought more than four billion doses for a population of four hundred million people.
Four billion for four hundred million.
That's ten doses per person.
Even accounting for boosters and buffer stock, that number is staggering.
Y una parte importante de esas dosis terminó en la basura o en países en desarrollo, pero muchas veces llegaron demasiado tarde o en malas condiciones.
And a significant portion of those doses ended up in the garbage or in developing countries, but often arrived too late or in poor condition.
Fue un desastre logístico y también moral.
It was a logistical and also a moral disaster.
That second part is worth naming plainly.
While wealthier countries were sitting on surplus doses they'd ordered in panic, large parts of Africa and South Asia were still waiting for first doses.
The maldistribution was obscene by any reasonable measure.
Es verdad.
It's true.
Y Pfizer ganó muchísimo dinero durante esos años.
And Pfizer made an enormous amount of money during those years.
En 2022, sus ganancias fueron de casi 100.000 millones de dólares.
In 2022, its revenues were close to 100 billion dollars.
Fue el año más rentable en la historia de la empresa.
It was the most profitable year in the company's history.
And a meaningful chunk of that came from public money.
Taxpayers in Europe, the US, everywhere.
Which is why this court case feels like more than just a contract dispute.
It's almost a reckoning about who bore the risk in the whole COVID procurement story.
Eso es exactamente lo que Polonia argumenta.
That's exactly what Poland is arguing.
El gobierno dice: nosotros tomamos el riesgo de comprar tantas dosis sin saber si funcionaban.
The government says: we took the risk of buying so many doses without knowing if they worked.
Y cuando vimos que no las necesitábamos, Pfizer no quiso negociar una solución diferente.
And when we saw we didn't need them, Pfizer refused to negotiate a different solution.
Was there any flexibility built into these contracts?
I've read that some countries managed to cancel portions of their orders.
The Netherlands renegotiated some tranches, I think.
Denmark canceled a contract with Moderna.
Sí, pero esos países lo hicieron muy pronto, cuando todavía era posible.
Yes, but those countries did it very early, when it was still possible.
Polonia esperó más tiempo y la situación se complicó.
Poland waited longer and the situation got more complicated.
Además, el gobierno polaco de ese momento no era el mismo que el gobierno actual.
Also, the Polish government at that time wasn't the same as the current government.
Esto también es política interna.
This is also domestic politics.
Ah.
Now that's interesting.
So the current government is appealing a bill it didn't run up.
That changes the political calculus completely.
They can frame this as fighting a corrupt deal struck by their predecessors.
Exactamente.
Exactly.
El gobierno actual en Polonia es el de Donald Tusk, que llegó al poder en 2023.
The current government in Poland is that of Donald Tusk, who came to power in 2023.
El contrato original lo firmó el gobierno del PiS, el partido conservador anterior.
The original contract was signed by the PiS government, the previous conservative party.
Así que para Tusk es fácil decir: nosotros no firmamos esto.
So for Tusk it's easy to say: we didn't sign this.
Which is clever, but it's also legally irrelevant.
Governments inherit obligations.
The state signed it.
The state owes it.
But politically, domestically, it gives Tusk a free shot at his opponents while looking like he's standing up to a pharmaceutical giant.
Sí.
Yes.
Y también hay un argumento más grande.
And there's also a bigger argument.
Polonia dice que Pfizer fue deshonesta durante las negociaciones.
Poland says Pfizer was dishonest during the negotiations.
Que prometió precios y condiciones que después cambió.
That it promised prices and conditions that it later changed.
Si eso es verdad, es diferente a simplemente no querer pagar.
If that's true, it's different from simply not wanting to pay.
That's the nub of what the appeal will turn on, I'd guess.
Was this a clean contract that Poland is just trying to escape, or were there misrepresentations during the negotiation process?
One of those is a breach of contract claim, the other is something closer to fraud.
Y mientras tanto, otros países están mirando.
And meanwhile, other countries are watching.
Rumanía también tiene problemas con dosis que no usó.
Romania also has problems with doses it didn't use.
Hay otros casos similares en Europa.
There are other similar cases in Europe.
Esta sentencia puede crear un precedente muy importante.
This ruling could set a very important precedent.
The precedent question is what makes this genuinely consequential beyond Poland.
Because governments are already starting to think about the next pandemic.
And if the lesson from COVID procurement is that you can be locked into catastrophically unfavorable contracts with no exit, that changes how every health ministry in the world should be operating.
Totalmente.
Totally.
Y hay una lección más para las empresas también.
And there's one more lesson for companies too.
Pfizer puede ganar este caso legalmente.
Pfizer may win this case legally.
Pero su imagen en Europa no es muy buena ahora mismo.
But its image in Europe isn't very good right now.
Muchos europeos piensan que la empresa se aprovechó de una crisis.
Many Europeans think the company took advantage of a crisis.
Winning the case and winning the argument aren't the same thing.
I've watched enough public health fights to know that being technically right while looking like you're squeezing a government over unused vaccines is a dangerous place to be as a company.
Exacto.
Exactly.
Y el Parlamento Europeo ya pidió más transparencia en estos contratos.
And the European Parliament has already called for more transparency in these contracts.
Hay políticos que quieren cambiar las reglas para la próxima vez.
There are politicians who want to change the rules for next time.
Quieren que los contratos sean públicos y que los países puedan cancelar más fácilmente en situaciones de emergencia.
They want contracts to be public and for countries to be able to cancel more easily in emergency situations.
That seems obviously right to me.
I understand the commercial sensitivities around contract terms.
But when you're talking about public health money and public health outcomes, the presumption should be transparency, not secrecy.
You want to be able to audit this stuff after the fact.
Sí.
Yes.
Y en el fondo, esta historia es sobre el poder.
And at its core, this story is about power.
Cuando hay una crisis, las empresas que tienen lo que los gobiernos necesitan tienen mucho poder.
When there's a crisis, companies that have what governments need have a lot of power.
Eso no va a cambiar.
That's not going to change.
Pero sí podemos preparar mejores contratos para la próxima vez.
But we can prepare better contracts for next time.
Octavio, oye, antes dijiste algo que me llamó la atención.
Dijiste que Polonia 'apeló' la sentencia.
Usar 'apelar' en español, ¿siempre es para un recurso legal?
Porque en inglés 'appeal' también puede significar...
atraer a alguien, o hacer un llamamiento.
Buena pregunta.
Good question.
En español, 'apelar' es casi siempre legal o formal.
In Spanish, 'apelar' is almost always legal or formal.
Decimos 'apelar una sentencia' o 'apelar una decisión'.
We say 'apelar una sentencia' (appeal a ruling) or 'apelar una decisión' (appeal a decision).
Para la idea de atraer, usamos 'atraer' o 'gustar'.
For the idea of attracting, we use 'atraer' or 'gustar'.
Por ejemplo, 'esa oferta no me atrae' o 'ese argumento no me convence'.
For example, 'esa oferta no me atrae' (that offer doesn't appeal to me) or 'ese argumento no me convence' (that argument doesn't appeal to me).
So if I said 'el contrato no me apela', meaning the contract doesn't appeal to me, that would sound like I'm filing a lawsuit against the contract.
Sí, exactamente.
Yes, exactly.
O sonaría muy raro.
Or it would sound very strange.
Lo correcto sería decir 'el contrato no me atrae' o 'el contrato no me interesa'.
The correct way would be 'el contrato no me atrae' or 'el contrato no me interesa'.
'Apelar' para cosas personales suena muy mal en español.
Using 'apelar' for personal things sounds very wrong in Spanish.
So: apelar for courts and legal decisions, atraer or interesar for when something catches your attention or you find it attractive.
I'll try to keep that separate.
Probably with the same success rate as my vocabulary experiments generally.
Mucho ánimo, Fletcher.
Keep it up, Fletcher.
Aunque, si cometes un error con 'apelar', al menos no le dirás a nadie que estás embarazado.
Although, if you make a mistake with 'apelar', at least you won't be telling anyone you're pregnant.